5 days Medicaid dominates coverage of Novo, Lilly weight-loss drugsFast Company

U.S. government health plans account for the lion’s share of coverage for popular new weight-loss drugs, far beyond the reimbursement available from private employers and insurers, according to an analysis shared with Reuters.

State Medicaid …

·